NCT04068207View on ClinicalTrials.gov

Minocycline Treatment in Retinitis Pigmentosa

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 25, 2019

Primary Completion Date

January 31, 2023

Study Completion Date

December 1, 2023

Conditions
Retinitis PigmentosaInherited Retinal DystrophyRetina Disorder
Interventions
DRUG

Minocycline

Tab. Minocycline 100mg po per day for 12 months

Trial Locations (1)

510060

Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT04068207 - Minocycline Treatment in Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter